(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 3.42% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.03%.
Thermo Fisher Scientific's revenue in 2025 is $43,212,000,000.On average, 10 Wall Street analysts forecast TMO's revenue for 2025 to be $16,573,786,819,235, with the lowest TMO revenue forecast at $16,462,398,418,171, and the highest TMO revenue forecast at $16,637,061,394,291. On average, 10 Wall Street analysts forecast TMO's revenue for 2026 to be $17,343,612,566,730, with the lowest TMO revenue forecast at $17,081,661,905,556, and the highest TMO revenue forecast at $17,702,078,620,359.
In 2027, TMO is forecast to generate $18,467,233,305,917 in revenue, with the lowest revenue forecast at $18,031,027,867,326 and the highest revenue forecast at $18,914,968,753,011.